DnB Asset Management
LEGN icon

DnB Asset Management’s Legend Biotech LEGN Stock Holding History

DnB Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
+9,587
New +$259K ﹤0.01% 1045
2025
Q4 		– Sell
-6,804
Closed -$222K – 752
2025
Q3 		$222K Hold
6,804
– – ﹤0.01% 707
2025
Q2 		$241K Buy
+6,804
New +$220K ﹤0.01% 684
2024
Q4 		– Sell
-5,095
Closed -$248K – 741
2024
Q3 		$248K Buy
5,095
+506
+11% +$27K ﹤0.01% 691
2024
Q2 		$203K Hold
4,589
– – ﹤0.01% 694
2024
Q1 		$257K Buy
+4,589
New +$277K ﹤0.01% 684

Other funds holding LEGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $587M AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DnB Asset Management's LEGN Position: Q2 2026 in Review

DnB Asset Management opened a new position in Legend Biotech (LEGN) in Q2 2026: 9,587 shares worth $277K. The stake represents ﹤0.01% of the portfolio and ranks #1045 among its holdings. This is a return to the name: DnB Asset Management previously reported a position in LEGN as recently as Q3 2025.

DnB Asset Management first reported a position in LEGN in Q1 2024 and has held it in 6 quarters since. 151 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • DnB Asset Management held 9,587 shares of Legend Biotech worth $277K as of Q2 2026.
  • Legend Biotech was a new DnB Asset Management position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #1045 holding.
  • DnB Asset Management first reported a position in Legend Biotech in Q1 2024 and has held it in 6 quarters since.
  • 151 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.